Back to the Top
Dear all,
When I read some textbook on PK, there are some views that really confusing me. Would you please
feel free give your comments to specify them?
2) One of the reasons for “sustained or elevated exposure at the beginning and the declining
for conc. vs t profile for IV administration” is “substrate inhibition of metabolism during the
initial phase”. I cannot understand the substrate inhibition of metabolism well herein.
Any comments on these views will be highly appreciated.
Thanks in advance,
MJ
Back to the Top
Hi MJ
Hans gave a very good explanation to your other question and I won’t be able to match that level but
try explaining it based on my understanding.
As you know some drugs can inhibit (reduce) enzymes activities. Now, if a drug inhibits the same
enzymes that contribute to its elimination then substrate inhibition of metabolism happens.
This inhibition can happen for different reasons, e.g. negative co-operatively or time-dependent
inhibition which both can cause non-linear elimination.
When you give an IV dose, the level of drug concentration at the beginning is high as a result the
level of inhibition is high so elimination is low and the drug level is sustained in the body.
When gradually the drug level goes down the level of inhibition goes down as well which speeds up
the elimination process so you have a faster decline in the concentration level.
Hope this helps.
Regards
Masoud
Back to the Top
Dear Dr. Masoud,
Thanks for nice explanation.
One query- If TDI is involved, can elimination increase as parent concentration reduces at later
time points ?
Thanks.
Regards.
Ravi
Back to the Top
Dear Ravi
Yes that can happen for TDI as well. As the substrate concentration goes down the level of
inhibition reduces and as a result elimination goes up. Of course the initial question was related
to auto-inhibition but this is the same when a TDI acts on a victim drug.
Regards
Masoud
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@lists.ucdenver.edu with "Substrate inhibition of metabolism" as the subject |
Copyright 1995-2014 David W. A. Bourne (david@boomer.org)